In the study of over 200 patients, 90.1% of those who received TC-325 had their bleeding controlled within 30 days, as compared to 81.4% of those who received standard treatment, meeting criteria for ...

Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Addressing intraoperative bleeding ...

On modern battlefields and city streets alike, the difference between life and death after a major injury is often measured in seconds. Now researchers say a new sprayable powder can halt catastrophic ...

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...

The agent, known as AGCL powder, was developed through a cross-disciplinary collaboration between materials science and biological engineering, with input from an active-duty South Korean Army ...

SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may be ...

Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Indications: PerClot ...